Skip to main content
. 2016 Jan 12;3:190–201. doi: 10.1016/j.toxrep.2016.01.007

Fig. 6.

Fig. 6

Plasma; The concentration (ng/mL) of TBBPA at 4- and 8-h following A 7, B 14, and C 28-days of dosing. Each bar represents the mean ± SD (n = 4–6 per group). (*) indicates a significant dose-related increasing trend (p < 0.01). (^) indicates a significant decrease in TBBPA concentration at each dose level at 8-h compared to the 4-h time point (p < 0.05).